Prospective cohort study of febrile neutropenia in breast cancer patients administered with neoadjuvant and adjuvant chemotherapies: CSPOR-BC FN study-Reference-Cited by-同舟云学术

Prospective cohort study of febrile neutropenia in breast cancer patients administered with neoadjuvant and adjuvant chemotherapies: CSPOR-BC FN study

Published:2021-04 Issue: Volume:56 Page:70-77
ISSN:0960-9776
Container-title:The Breast
language:en
Short-container-title:The Breast

Author:

Ishikawa Takashi,Sakamaki Kentaro^ORCID,Narui Kazutaka,Nishimura Hideki,Sangai Takafumi^ORCID,Tamaki Kentaro,Hasegawa Yoshie,Watanabe Ken-ichi,Suganuma Nobuyasu,Michishita Shintaro,Sugae Sadatoshi^ORCID,Aihara Tomohiko^ORCID,Tsugawa Koichiro,Kaise Hirose,Taira Naruto^ORCID,Mukai Hirofumi

Publisher

Elsevier BV

Subject

General Medicine,Surgery

Reference25 articles.

1. Risk of chemotherapy-induced febrile neutropenia with early discontinuation of pegfilgrastim prophylaxis in US clinical practice;Weycker;Support Care Canc,2016

2. Prophylactic granulocyte colony-stimulating factor in patients receiving dose-intensive cancer chemotherapy: a meta-analysis;Lyman;Am J Med,2002

3. Impact of primary prophylaxis with granulocyte colony-stimulating factor on febrile neutropenia and mortality in adult cancer patients receiving chemotherapy: a systematic review;Kuderer;J Clin Oncol,2007

4. Mortality, morbidity, and cost associated with febrile neutropenia in adult cancer patients;Kuderer;Cancer,2006

5. Epidemiology of febrile neutropenia;Lyman;Support Canc Ther,2003

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of PEG-GCSF in Breast Cancer Patients Undergoing Chemotherapy During the COVID-19 Pandemic: Single Center Experience and Literature Review;In Vivo;2024

2. Association Between Treated Periodontal Disease and Febrile Neutropenia in Perioperative Chemotherapy for Breast Cancer: A Retrospective Cohort Study;Cureus;2023-12-30

3. An observational, prospective, open label, multicenter study to evaluate the safety and effectiveness of pegfilgrastim as secondary prophylaxis to decrease the incidence of febrile neutropenia in Korean female patients with breast cancer;The Breast;2023-12

4. Effectiveness and Safety of Originator and Biosimilar G-CSF as Primary Prophylaxis in DLBCL: A Cohort Study and Meta-Analysis;2023-09-11

5. How Asian Breast Cancer Patients Experience Unequal Incidence of Chemotherapy Side Effects: A Look at Ethnic Disparities in Febrile Neutropenia Rates;Cancers;2023-07-12